Renerve (ASX:RNV) Days Inventory: 380.21 (As of Dec. 2025) — 85% Below Median

What is Renerve Days Inventory?

Renerve ASX:RNV +1.27% Days Inventory is 380.21 as of Dec. 2025, which is 85% below its 10-year median of 2,555.00. The stock has 5 warning signs investors should review. Among 636 Biotechnology companies, Renerve ranks worse than 83.96% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). Renerve's Average Total Inventories for the six months ended in Dec. 2025 was A$0.25 Mil. Renerve's Cost of Goods Sold for the six months ended in Dec. 2025 was A$0.12 Mil. Hence, Renerve's Days Inventory for the six months ended in Dec. 2025 was 380.21.

The historical rank and industry rank for Renerve's Days Inventory or its related term are showing as below:

ASX:RNV' s Days Inventory Range Over the Past 10 Years
Min: 567.22 Med: 2555 Max: 2555
Current: 567.22

During the past 4 years, Renerve's highest Days Inventory was 2555.00. The lowest was 567.22. And the median was 2555.00.

ASX:RNV's Days Inventory is ranked worse than
83.96% of 636 companies
in the Biotechnology industry
Industry Median: 183.195 vs ASX:RNV: 567.22

Renerve's Days Inventory declined from Dec. 2024 (16,151.25) to Dec. 2025 (380.21).

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Renerve's Inventory Turnover for the six months ended in Dec. 2025 was 0.48.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Renerve's Inventory-to-Revenue for the six months ended in Dec. 2025 was 1.52.

Renerve (ASX:RNV) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Renerve's Inventory Turnover for the six months ended in Dec. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.12	/	0.25
	=	0.48

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Renerve's Inventory to Revenue for the six months ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.25	/	0.164
	=	1.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Renerve Days Inventory Related Terms

Renerve Days Inventory Historical Data

* Premium members only.

The historical data trend for Renerve's Days Inventory can be seen below:

Renerve Days Inventory Chart

Renerve Annual Data

Trend

Jun22

Jun23

Jun24

Jun25

Days Inventory

0.00

2,555.00

Renerve Semi-Annual Data
	Jun22	Jun23	Jun24	Dec24	Jun25	Dec25
Days Inventory	Get a 7-Day Free Trial			0.00	0.00	16,151.25	1,372.40	380.21

ASX:RNV vs VRTX, REGN, ALNY: Days Inventory Comparison

For the Biotechnology subindustry, Renerve's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Renerve Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Renerve's Days Inventory distribution charts can be found below:

* The bar in red indicates where Renerve's Days Inventory falls into.

Save Embed

Renerve Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Renerve's Days Inventory for the fiscal year that ended in Jun. 2025 is calculated as

	Days Inventory (A: Jun. 2025 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Jun. 2024 )	+	Total Inventories (A: Jun. 2025 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2025 )	*	Days in Period
=	( (0.178	+	0.2)	/	2 )	/	0.027	*	365
=	0.189					/	0.027	*	365
=	2,555.00

Renerve's Days Inventory for the quarter that ended in Dec. 2025 is calculated as:

	Days Inventory (Q: Dec. 2025 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2025 )	+	Total Inventories (Q: Dec. 2025 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
=	( (0.2	+	0.3)	/	2 )	/	0.12	*	365 / 2
=	0.25					/	0.12	*	365 / 2
=	380.21

Frequently Asked Questions Learn more about Days Inventory →

What does a Days Inventory of 380.21 mean?

Renerve (ASX:RNV) has a Days Inventory of 380.21 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Renerve and its competitors. This is 85% below median its historical median of 2,555.00. Over the past decade, Renerve's Days Inventory has ranged from 567.22 to 2,555.00. According to the industry distribution chart, Renerve ranks #534 out of 636 companies in the Biotechnology industry, placing it in the top 84%.

Is Renerve's Days Inventory too high?

Renerve's current Days Inventory of 380.21 is 85% below median its 10-year median of 2,555.00. Over the past 10 years, this metric has ranged from a low of 567.22 to a high of 2,555.00. The Biotechnology industry median Days Inventory is 183.20. Renerve's value of 380.21 is 107.5% above this industry median. Based on the distribution chart, Renerve ranks #534 out of 636 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.

How does Renerve's Days Inventory compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Renerve ranks #534 out of 636 companies for Days Inventory. This places Renerve in the lower half of its industry. The industry median Days Inventory is 183.20. Renerve's value of 380.21 is 107.5% above this benchmark. Historically, Renerve's own Days Inventory has ranged from 567.22 to 2,555.00 over the past decade. While the company's 10-year median is 2,555.00 vs. the industry median of 183.20, Renerve has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Inventory for a Biotechnology company?

The median Days Inventory among Biotechnology companies is 183.20, based on 636 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Renerve's current Days Inventory of 380.21 is 107.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Inventory mean?

A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Renerve and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Renerve's current Days Inventory is 380.21, which is 85% below median its own 10-year median of 2,555.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Renerve stock overvalued right now?

Renerve (ASX:RNV) has a current Days Inventory of 380.21. The current Days Inventory is 380.21, which is 85% below median its 10-year median of 2,555.00 and 107.5% above the Biotechnology industry median of 183.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Inventory calculated?

Days Inventory is calculated from a company's financial statements. For Renerve (ASX:RNV), the current Days Inventory is 380.21 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Renerve Business Description

Industry Healthcare Biotechnology

Comparable Companies ASX:AGN ASX:CMB ASX:IMC ASX:NTI ASX:PIQ ASX:OPT ASX:EZZ ASX:BIT ASX:BGT ASX:VBS VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 157 Heidelberg Road, Northcote, VIC, AUS, 3070

Website https://renerve.com.au

Renerve Ltd specializes in developing a range of ready-to-use products that are cleaner, safer for repairing or replacing damaged peripheral nerves, resulting in good patient outcomes. Its product candidates include NervAlign Bionic Nerve, NervAlign Nerve Graft, and NervAlign Nerve Cuff [The NervAlign Nerve Guide Matrix, The NervAlign Nerve Conduit, The NervAlign Bionic Replacement Nerve]. The company operates in New Zealand and USA. Maximum of revenue is from USA.